New York, United States, Mar 27, 2022, 10:59 /Comserve / -- Top Key Players Covered By Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc

Research Nester published a report titled “Direct Ophthalmoscope Market : Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global direct ophthalmoscope market in terms of market segmentation by application, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global direct ophthalmoscope market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2022 – 2031. The market is segmented on the basis of application into glaucoma, retinal tear, diabetes, and others, out of which, the diabetes segment is anticipated to hold a substantial share in the market over the forecast period. This can be attributed to the high prevalence of diabetes combined with the high risk of diabetes-induced blindness, globally. According to the WHO data, diabetic retinopathy caused partial blindness in 3.9 million people, as of 2020, worldwide.

Download a Sample Report with Table of Contents and Figures:

The global direct ophthalmoscope market is estimated to grow on the back of increasing incidences of ocular disorders, especially amongst the older population, along with rising geriatric population globally. According to the data by the World Bank, 9.318% of the total global population was above 65 years, in 2020. In addition to this, growing awareness regarding optical diseases, is also estimated to boost the market growth.

On the basis of geographical analysis, the global direct ophthalmoscope market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing prevalence of eye-related disorders, along with higher health awareness across the region. As per the data by the Center for Disease Control and Prevention (CDC), 3 million individuals in the U.S. have glaucoma.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Growing Incidences of Visual Impairment to Boost the Market Growth

According to the data by the World Health Organization (WHO), more than 4.2 million people lose vision due to corneal opacities every year.

Prevalence of various diseases, such as, glaucoma, retinal or corneal tears, and diabetes-induced blindness is the major factor estimated to boost the demand for direct ophthalmoscope. The growing awareness regarding ophthalmological health amongst the people, is estimated to boost the market growth. Moreover, rising government initiatives to reduce cases of blindness is estimated to further boost the market growth.

However, the lack of awareness about ocular diseases and high cost of direct ophthalmoscope are expected to operate as key restraint to the growth of global direct ophthalmoscope market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global direct ophthalmoscope market which includes company profiling of Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, and Pfizer Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global direct ophthalmoscope market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Get a Sample Copy Of This Report With Graphs and Charts : 

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

MENAFN27032022004694010674ID1103921536